STAT5A and neoplasm: As blocking IL15‐stat5a axis significantly dampened the Sell(hi) neutrophil‐mediated tumor cell killing capacity of p‐Stat5+ Tpex, we next assessed whether blocking this axis also reduced the antitumor efficacy of the C‐P regimen in MOC2 tumor‐bearing mice in vivo (Figure S7a, Supporting Information).